Clinical Trials
2 trialsNCT05460533 2026-02-04
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02167360 2017-02-14
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn